Contact Information
Company Information
Company
Hemab Therapeutics
Total Funding
190000000.0
Technologies
Outlook
Microsoft Office 365
Google Cloud Hosting
Nginx
WordPress.org
Google Tag Manager
Mobile Friendly
Typekit
Remote
Keywords
biotech
biotechnology research
hemab
bleeding disorders
thrombotic disorders
prophylactic treatments
therapeutic solutions
bispecific antibody
hmb-001
clinical trials
factor vii deficiency
glanzmann thrombasthenia
von willebrand disease
functional cures
endogenous clotting factors
hemostatic plugs
safety & efficacy
monoclonal antibodies
lifesaving therapies
patient care
innovative treatments
orphan drug designation
blood clotting
medical research
rare diseases
high unmet need
clinical evaluation
advanced technologies
drug discovery
biologics
preventive medicine
treatment paradigm
hemophilia b
hereditary hemorrhagic telangiectasia
congenital antithrombin iii deficiency
recruitment of factors
pharmacodynamics
pharmacokinetics
subcutaneous administration
dose-dependent response
high affinity
therapeutic levels
phase 2 study
patient engagement
clinical endpoints
sustained efficacy
therapeutic innovation
medical advancements
rare clotting disorders
treatment gaps
social impact
quality of life improvement
health care
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans